DGAP-News

CVR Medical Announces Independent Report on Clinical Trial Results from Thomas Jefferson University Hospital

DGAP-News: CVR Medical Corp. / Key word(s): Miscellaneous CVR Medical Announces Independent Report on Clinical Trial Results from Thomas Jefferson University Hospital 29.06.2017 / 18:36 The issuer is solely responsible for the content of this announcement. Vancouver, British Columbia--(Newsfile Corp. - June 29, 2017) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ('CVR Medical') is pleased to announce that Thomas Jefferson University Hospital — Jefferson Clinical Research Institute has issued an initial trial report, summarizing the clinical trial progress of the Carotid Stenotic Scan (CSS) under the supervision of Principal Investigator Dr. David Whellan MD, MHS, FACC, FAHA.

Dr. Whellan commented, 'The ENTICES (Evaluation of a Novel Technique to Investigate CAS piezo-Electric Sensors) Study, which is studying the CVR's Carotid Stenotic Scan (CSS) against current ultrasound technology, continues to enroll at a robust pace. The Jefferson Clinical Research Institute currently has data on over 125 within the study. A major factor in the successful enrollment has been the ease at which CSS data can be acquired, which allows participants to have test studies performed quickly. We look forward to completing enrollment and having results to share.'

To view the full report, please go to http://cvrmed.com/wp-content/uploads/2017/06/Clinical-trial-report.pdf.

To view an enhanced version of Page 1 of the Study, please visit:
http://orders.newsfilecorp.com/files/1933/27717_a1498750122646_2.jpg

To view an enhanced version of Page 2 of the Study, please visit:
http://orders.newsfilecorp.com/files/1933/27717_a1498750123177_76.jpg

To view an enhanced version of Page 3 of the Study, please visit:
http://orders.newsfilecorp.com/files/1933/27717_a1498750123724_85.jpg

For additional information on the organization, leadership, and current news please visit the company website at www.CVRMed.com.

About CVR Medical

CVR Medical is a company that is involved in an equal parts joint venture with CVR Global Inc. (the 'Joint Venture'). The Joint Venture operates in the medical industry focused on the commercialization of a proprietary subsonic, infrasonic, and low frequency sound wave analysis technology and has patents to a diagnostic device designed to detect and measure carotid arterial stenosis. CVR Medical is managed by a proven technical team. CVR Medical trades on the TSX Venture Exchange under the symbol CVM.